Activating CaSR mutations cause autosomal dominant hypocalcaemia type-1 (ADH1), characterised by mild-to-moderate hypocalcaemia, with inappropriately low-to-normal serum PTH (Pearce et al. 1996). Here, CASR is linked to Hypocalcemia.